 | • レポートコード：MRC2102QY8121 • 出版社/出版日： / 2021年1月 • レポート形態：英文、PDF、136ページ • 納品方法：Eメール（受注後2~3営業日） • 産業分類：医薬品、医療 |
| Single User | ￥600,000 (USD4,000) | ▷ お問い合わせ |
| Multi User | ￥900,000 (USD6,000) | ▷ お問い合わせ |
| Enterprise License | ￥1,200,000 (USD8,000) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYリサーチ社の本調査レポートでは、世界のリポソーム化ドキソルビシン市場について種類別（5ml、10ml、25ml）、用途別（乳がん、肝臓がん、腎臓がん、多発性骨髄腫、卵巣がん、その他）、地域別（米国、ヨーロッパ、中国、日本、東南アジア、インド）に区分して調査し、纏めました。2015年～2026年までの市場規模予測、主要プレイヤーの競争状況・市場シェア・企業情報、製造コスト分析、販売チャネル・流通業者・顧客情報、市場動向・機会・課題などのマーケットデータが記載されています。市場予測データは新型コロナウイルスの影響を反映させました。 ・リポソーム化ドキソルビシン市場の概要 ・世界の主要地域別リポソーム化ドキソルビシン市場規模2015-2026 ・主要プレイヤーの競争状況・市場シェア ・世界のリポソーム化ドキソルビシン市場規模2015-2026：種類別（5ml、10ml、25ml） ・世界のリポソーム化ドキソルビシン市場規模2015-2026：用途別（乳がん、肝臓がん、腎臓がん、多発性骨髄腫、卵巣がん、その他） ・リポソーム化ドキソルビシンの米国市場規模2015-2020 ・リポソーム化ドキソルビシンのヨーロッパ市場規模2015-2020 ・リポソーム化ドキソルビシンの中国市場規模2015-2020 ・リポソーム化ドキソルビシンの日本市場規模2015-2020 ・リポソーム化ドキソルビシンの東南アジア市場規模2015-2020 ・リポソーム化ドキソルビシンのインド市場規模2015-2020 ・主要プレイヤーの企業情報：事業概要・売上・企業動向 ・リポソーム化ドキソルビシンの製造コスト分析 ・販売チャネル、流通業者、顧客 ・リポソーム化ドキソルビシンの市場動向・機会・課題 ・調査の結論 |
Liposome doxorubicin is a commonly used anthracycline anti-tumor drug, and is one of the first-line drugs for ovarian cancer.
Market competition is intense. Johnson & Johnson, Sun Pharmaceutical, CSPC, etc. are the leaders of the industry, and they hold key technologies and patents, with high-end customers. Top 3 accounted for 60.41% market share.
Market Analysis and Insights: Global Liposomal Doxorubicin Market
The global Liposomal Doxorubicin market size is projected to reach US$ 1844 million by 2026, from US$ 1183.6 million in 2020, at a CAGR of 7.7% during 2021-2026.
Global Liposomal Doxorubicin Scope and Market Size
The global Liposomal Doxorubicin market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Liposomal Doxorubicin market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type and by Application for the period 2015-2026.
Segment by Type, the Liposomal Doxorubicin market is segmented into
5 ml
10 ml
25 ml
The classification of liposomal doxorubicin includes 5ml, 10 ml, etc. And the proportion of 10ml in 2020 is estimated about 88.77%.
Segment by Application, the Liposomal Doxorubicin market is segmented into
Breast Cancer
Liver Cancer
Kidney Cancer
Multiple Myeloma
Ovarian Cancer
Other
Liposomal doxorubicin is widely in breast cancer, liver cancer, kidney cancer, multiple myeloma, ovarian cancer, etc. the proportion of breast cancer in 2020 will be about 21.6%.
The Liposomal Doxorubicin market is analysed and market size information is provided by regions (countries). Segment by Application, the Liposomal Doxorubicin market is segmented into United States, Europe, China, Japan, Southeast Asia, India and Rest of World.
The report includes region-wise market size for the period 2015-2026. It also includes market size and forecast by players, by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Liposomal Doxorubicin Market Share Analysis
Liposomal Doxorubicin market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Liposomal Doxorubicin business, the date to enter into the Liposomal Doxorubicin market, Liposomal Doxorubicin product introduction, recent developments, etc.
The major vendors covered:
Johnson & Johnson
Sun Pharmaceutical
CSPC
Kinyond
Teva
Fudan-Zhangjiang
Zydus Cadila
TTY Biopharma
1 Liposomal Doxorubicin Market Overview
1.1 Liposomal Doxorubicin Product Scope
1.2 Liposomal Doxorubicin Segment by Type
1.2.1 Global Liposomal Doxorubicin Sales by Type (2020-2026)
1.2.2 5 ml
1.2.3 10 ml
1.2.4 25 ml
1.3 Liposomal Doxorubicin Segment by Application
1.3.1 Global Liposomal Doxorubicin Sales Comparison by Application (2020-2026)
1.3.2 Breast Cancer
1.3.3 Liver Cancer
1.3.4 Kidney Cancer
1.3.5 Multiple Myeloma
1.3.6 Ovarian Cancer
1.3.7 Other
1.4 Liposomal Doxorubicin Market Estimates and Forecasts (2015-2026)
1.4.1 Global Liposomal Doxorubicin Sales Growth Rate (2015-2026)
1.4.2 Global Liposomal Doxorubicin Revenue and Growth Rate (2015-2026)
1.4.3 Global Liposomal Doxorubicin Price Trends (2015-2026)
2 Liposomal Doxorubicin Estimate and Forecast by Region
2.1 Global Liposomal Doxorubicin Market Size by Region: 2015 VS 2020 VS 2026
2.2 Global Liposomal Doxorubicin Retrospective Market Scenario by Region (2015-2020)
2.2.1 Global Liposomal Doxorubicin Sales Market Share by Region (2015-2020)
2.2.2 Global Liposomal Doxorubicin Revenue Market Share by Region (2015-2020)
2.3 Global Liposomal Doxorubicin Market Estimates and Forecasts by Region (2021-2026)
2.3.1 Global Liposomal Doxorubicin Sales Estimates and Forecasts by Region (2021-2026)
2.3.2 Global Liposomal Doxorubicin Revenue Forecast by Region (2021-2026)
2.4 Geographic Market Analysis: Market Facts & Figures
2.4.1 United States Liposomal Doxorubicin Estimates and Projections (2015-2026)
2.4.2 Europe Liposomal Doxorubicin Estimates and Projections (2015-2026)
2.4.3 China Liposomal Doxorubicin Estimates and Projections (2015-2026)
2.4.4 Japan Liposomal Doxorubicin Estimates and Projections (2015-2026)
2.4.5 Southeast Asia Liposomal Doxorubicin Estimates and Projections (2015-2026)
2.4.6 India Liposomal Doxorubicin Estimates and Projections (2015-2026)
3 Global Liposomal Doxorubicin Competition Landscape by Players
3.1 Global Top Liposomal Doxorubicin Players by Sales (2015-2020)
3.2 Global Top Liposomal Doxorubicin Players by Revenue (2015-2020)
3.3 Global Liposomal Doxorubicin Market Share by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Liposomal Doxorubicin as of 2019)
3.4 Global Liposomal Doxorubicin Average Price by Company (2015-2020)
3.5 Manufacturers Liposomal Doxorubicin Manufacturing Sites, Area Served, Product Type
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3.7 Primary Interviews with Key Liposomal Doxorubicin Players (Opinion Leaders)
4 Global Liposomal Doxorubicin Market Size by Type
4.1 Global Liposomal Doxorubicin Historic Market Review by Type (2015-2020)
4.1.1 Global Liposomal Doxorubicin Sales Market Share by Type (2015-2020)
4.1.2 Global Liposomal Doxorubicin Revenue Market Share by Type (2015-2020)
4.1.3 Global Liposomal Doxorubicin Price by Type (2015-2020)
4.2 Global Liposomal Doxorubicin Market Estimates and Forecasts by Type (2021-2026)
4.2.1 Global Liposomal Doxorubicin Sales Forecast by Type (2021-2026)
4.2.2 Global Liposomal Doxorubicin Revenue Forecast by Type (2021-2026)
4.2.3 Global Liposomal Doxorubicin Price Forecast by Type (2021-2026)
5 Global Liposomal Doxorubicin Market Size by Application
5.1 Global Liposomal Doxorubicin Historic Market Review by Application (2015-2020)
5.1.1 Global Liposomal Doxorubicin Sales Market Share by Application (2015-2020)
5.1.2 Global Liposomal Doxorubicin Revenue Market Share by Application (2015-2020)
5.1.3 Global Liposomal Doxorubicin Price by Application (2015-2020)
5.2 Global Liposomal Doxorubicin Market Estimates and Forecasts by Application (2021-2026)
5.2.1 Global Liposomal Doxorubicin Sales Forecast by Application (2021-2026)
5.2.2 Global Liposomal Doxorubicin Revenue Forecast by Application (2021-2026)
5.2.3 Global Liposomal Doxorubicin Price Forecast by Application (2021-2026)
6 United States Liposomal Doxorubicin Market Facts & Figures
6.1 United States Liposomal Doxorubicin Sales Market Share by Company (2015-2020)
6.2 United States Liposomal Doxorubicin Sales Market Share by Type (2015-2020)
6.3 United States Liposomal Doxorubicin Sales Market Share by Application (2015-2020)
7 Europe Liposomal Doxorubicin Market Facts & Figures
7.1 Europe Liposomal Doxorubicin Sales Market Share by Company (2015-2020)
7.2 Europe Liposomal Doxorubicin Sales Market Share by Type (2015-2020)
7.3 Europe Liposomal Doxorubicin Sales Market Share by Application (2015-2020)
8 China Liposomal Doxorubicin Market Facts & Figures
8.1 China Liposomal Doxorubicin Sales Market Share by Company (2015-2020)
8.2 China Liposomal Doxorubicin Sales Market Share by Type (2015-2020)
8.3 China Liposomal Doxorubicin Sales Market Share by Application (2015-2020)
9 Japan Liposomal Doxorubicin Market Facts & Figures
9.1 Japan Liposomal Doxorubicin Sales Market Share by Company (3015-3030)
9.2 Japan Liposomal Doxorubicin Sales Market Share by Type (2015-2020)
9.3 Japan Liposomal Doxorubicin Sales Market Share by Application (2015-2020)
10 Southeast Asia Liposomal Doxorubicin Market Facts & Figures
10.1 Southeast Asia Liposomal Doxorubicin Sales Market Share by Company (2015-2020)
10.2 Southeast Asia Liposomal Doxorubicin Sales Market Share by Type (2015-2020)
10.3 Southeast Asia Liposomal Doxorubicin Sales Market Share by Application (2015-2020)
11 India Liposomal Doxorubicin Market Facts & Figures
11.1 India Liposomal Doxorubicin Sales Market Share by Company (2015-2020)
11.2 India Liposomal Doxorubicin Sales Market Share by Type (2015-2020)
11.3 India Liposomal Doxorubicin Sales Market Share by Application (2015-2020)
12 Company Profiles and Key Figures in Liposomal Doxorubicin Business
12.1 Johnson & Johnson
12.1.1 Johnson & Johnson Corporation Information
12.1.2 Johnson & Johnson Business Overview
12.1.3 Johnson & Johnson Liposomal Doxorubicin Sales, Revenue and Gross Margin (2015-2020)
12.1.4 Johnson & Johnson Liposomal Doxorubicin Products Offered
12.1.5 Johnson & Johnson Recent Development
12.2 Sun Pharmaceutical
12.2.1 Sun Pharmaceutical Corporation Information
12.2.2 Sun Pharmaceutical Business Overview
12.2.3 Sun Pharmaceutical Liposomal Doxorubicin Sales, Revenue and Gross Margin (2015-2020)
12.2.4 Sun Pharmaceutical Liposomal Doxorubicin Products Offered
12.2.5 Sun Pharmaceutical Recent Development
12.3 CSPC
12.3.1 CSPC Corporation Information
12.3.2 CSPC Business Overview
12.3.3 CSPC Liposomal Doxorubicin Sales, Revenue and Gross Margin (2015-2020)
12.3.4 CSPC Liposomal Doxorubicin Products Offered
12.3.5 CSPC Recent Development
12.4 Kinyond
12.4.1 Kinyond Corporation Information
12.4.2 Kinyond Business Overview
12.4.3 Kinyond Liposomal Doxorubicin Sales, Revenue and Gross Margin (2015-2020)
12.4.4 Kinyond Liposomal Doxorubicin Products Offered
12.4.5 Kinyond Recent Development
12.5 Teva
12.5.1 Teva Corporation Information
12.5.2 Teva Business Overview
12.5.3 Teva Liposomal Doxorubicin Sales, Revenue and Gross Margin (2015-2020)
12.5.4 Teva Liposomal Doxorubicin Products Offered
12.5.5 Teva Recent Development
12.6 Fudan-Zhangjiang
12.6.1 Fudan-Zhangjiang Corporation Information
12.6.2 Fudan-Zhangjiang Business Overview
12.6.3 Fudan-Zhangjiang Liposomal Doxorubicin Sales, Revenue and Gross Margin (2015-2020)
12.6.4 Fudan-Zhangjiang Liposomal Doxorubicin Products Offered
12.6.5 Fudan-Zhangjiang Recent Development
12.7 Zydus Cadila
12.7.1 Zydus Cadila Corporation Information
12.7.2 Zydus Cadila Business Overview
12.7.3 Zydus Cadila Liposomal Doxorubicin Sales, Revenue and Gross Margin (2015-2020)
12.7.4 Zydus Cadila Liposomal Doxorubicin Products Offered
12.7.5 Zydus Cadila Recent Development
12.8 TTY Biopharma
12.8.1 TTY Biopharma Corporation Information
12.8.2 TTY Biopharma Business Overview
12.8.3 TTY Biopharma Liposomal Doxorubicin Sales, Revenue and Gross Margin (2015-2020)
12.8.4 TTY Biopharma Liposomal Doxorubicin Products Offered
12.8.5 TTY Biopharma Recent Development
13 Liposomal Doxorubicin Manufacturing Cost Analysis
13.1 Liposomal Doxorubicin Key Raw Materials Analysis
13.1.1 Key Raw Materials
13.1.2 Key Raw Materials Price Trend
13.1.3 Key Suppliers of Raw Materials
13.2 Proportion of Manufacturing Cost Structure
13.3 Manufacturing Process Analysis of Liposomal Doxorubicin
13.4 Liposomal Doxorubicin Industrial Chain Analysis
14 Marketing Channel, Distributors and Customers
14.1 Marketing Channel
14.2 Liposomal Doxorubicin Distributors List
14.3 Liposomal Doxorubicin Customers
15 Market Dynamics
15.1 Liposomal Doxorubicin Market Trends
15.2 Liposomal Doxorubicin Opportunities and Drivers
15.3 Liposomal Doxorubicin Market Challenges
15.4 Liposomal Doxorubicin Market Restraints
15.5 Porter’s Five Forces Analysis
16 Research Findings and Conclusion
17 Appendix
17.1 Research Methodology
17.1.1 Methodology/Research Approach
17.1.2 Data Source
17.2 Author List
17.3 Disclaimer
Table 1. Global Liposomal Doxorubicin Sales (K Unit) Growth Rate by Type (2020-2026) (US$ Million)
Table 2. Global Liposomal Doxorubicin Sales (K Unit) Comparison by Application (2020-2026) (US$ Million)
Table 3. Global Market Liposomal Doxorubicin Market Size (US$ Million) by Region:2015 VS 2020 &2026
Table 4. Global Liposomal Doxorubicin Sales (K Unit) by Region (2015-2020)
Table 5. Global Liposomal Doxorubicin Sales Market Share by Region (2015-2020)
Table 6. Global Liposomal Doxorubicin Revenue (US$ Million) Market Share by Region (2015-2020))
Table 7. Global Liposomal Doxorubicin Revenue Share by Region (2015-2020)
Table 8. Global Liposomal Doxorubicin Sales (K Unit) Forecast by Region (2021-2026)
Table 9. Global Liposomal Doxorubicin Sales Market Share Forecast by Region (2021-2026)
Table 10. Global Liposomal Doxorubicin Revenue (US$ Million) Forecast by Region (2021-2026)
Table 11. Global Liposomal Doxorubicin Revenue Share Forecast by Region (2021-2026)
Table 12. Global Liposomal Doxorubicin (K Unit) of Key Companies (2015-2020)
Table 13. Global Liposomal Doxorubicin Sales Share by Company (2015-2020)
Table 14. Global Liposomal Doxorubicin Revenue (US$ Million) by Company (2015-2020)
Table 15. Global Liposomal Doxorubicin Revenue Share by Company (2015-2020)
Table 16. Global Liposomal Doxorubicin by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Liposomal Doxorubicin as of 2019)
Table 17. Global Liposomal Doxorubicin Average Price (USD/Unit) of Key Company (2015-2020)
Table 18. Manufacturers Liposomal Doxorubicin Manufacturing Sites and Area Served
Table 19. Manufacturers Liposomal Doxorubicin Product Type
Table 20. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 21. Main Points Interviewed from Key Liposomal Doxorubicin Players
Table 22. Global Liposomal Doxorubicin Sales (K Unit) by Type (2015-2020)
Table 23. Global Liposomal Doxorubicin Sales Share by Type (2015-2020)
Table 24. Global Liposomal Doxorubicin Revenue (US$ Million) Market Share by Type (2015-2020)
Table 25. Global Liposomal Doxorubicin Price (K Unit) by Type (2015-2020)
Table 26. Global Liposomal Doxorubicin Sales Share by Type (2021-2026)
Table 27. Global Liposomal Doxorubicin Revenue (US$ Million) Market Share by Type (2021-2026)
Table 28. Global Liposomal Doxorubicin Revenue Share by Type (2021-2026)
Table 29. Global Liposomal Doxorubicin Price (K Unit) by Type (2021-2026)
Table 30. Global Liposomal Doxorubicin Sales (K Unit) by Application (2015-2020)
Table 31. Global Liposomal Doxorubicin Sales Share by Application (2015-2020)
Table 32. Global Liposomal Doxorubicin Revenue (US$ Million) Market Share by Application (2015-2020)
Table 33. Global Liposomal Doxorubicin Price (K Unit) by Application (2015-2020)
Table 34. Global Liposomal Doxorubicin Sales (K Unit) by Application (2021-2026)
Table 35. Global Liposomal Doxorubicin Sales Share by Application (2021-2026)
Table 36. Global Liposomal Doxorubicin Revenue (US$ Million) Market Share by Application (2021-2026)
Table 37. Global Liposomal Doxorubicin Revenue Share by Application (2021-2026)
Table 38. Global Liposomal Doxorubicin Price (K Unit) by Application (2021-2026)
Table 39. United States Liposomal Doxorubicin Sales (K Unit) by Company (2015-2020)
Table 40. United States Liposomal Doxorubicin Sales Market Share by Company (2015-2020)
Table 41. United States Liposomal Doxorubicin Sales (K Unit) by Type (2015-2020)
Table 42. United States Liposomal Doxorubicin Sales Market Share by Type (2015-2020)
Table 43. United States Liposomal Doxorubicin Sales (K Unit) by Application (2015-2020)
Table 44. United States Liposomal Doxorubicin Sales Market Share by Application (2015-2020)
Table 45. Europe Liposomal Doxorubicin Sales (K Unit) by Company (2015-2020)
Table 46. Europe Liposomal Doxorubicin Sales Market Share by Company (2015-2020)
Table 47. Europe Liposomal Doxorubicin Sales (K Unit) by Type (2015-2020)
Table 48. Europe Liposomal Doxorubicin Sales Market Share by Type (2015-2020)
Table 49. Europe Liposomal Doxorubicin Sales (K Unit) by Application (2015-2020)
Table 50. Europe Liposomal Doxorubicin Sales Market Share by Type (2015-2020)
Table 51. China Liposomal Doxorubicin Sales (K Unit) by Company (2015-2020)
Table 52. China Liposomal Doxorubicin Sales Market Share by Company (2015-2020)
Table 53. China Liposomal Doxorubicin Sales (K Unit) by Type (2015-2020)
Table 54. China Liposomal Doxorubicin Sales Market Share by Type (2015-2020)
Table 55. China Liposomal Doxorubicin Sales (K Unit) by Application (2015-2020)
Table 56. China Liposomal Doxorubicin Sales Market Share by Application (2015-2020)
Table 57. Japan Liposomal Doxorubicin Sales (K Unit) by Company (2015-2020)
Table 58. Japan Liposomal Doxorubicin Sales Market Share by Company (2015-2020)
Table 59. Japan Liposomal Doxorubicin Sales (K Unit) by Type (2015-2020)
Table 60. Japan Liposomal Doxorubicin Sales Market Share by Type (2015-2020)
Table 61. Japan Liposomal Doxorubicin Sales (K Unit) by Application (2015-2020)
Table 62. Japan Liposomal Doxorubicin Sales Market Share by Application (2015-2020)
Table 63. Southeast Asia Liposomal Doxorubicin Sales (K Unit) by Company (2015-2020)
Table 64. Southeast Asia Liposomal Doxorubicin Sales Market Share by Company (2015-2020)
Table 65. Southeast Asia Liposomal Doxorubicin Sales (K Unit) by Type (2015-2020)
Table 66. Southeast Asia Liposomal Doxorubicin Sales Market Share by Type (2015-2020)
Table 67. Southeast Asia Liposomal Doxorubicin Sales (K Unit) by Type (2015-2020)
Table 68. Southeast Asia Liposomal Doxorubicin Sales Market Share by Application (2015-2020)
Table 69. India Liposomal Doxorubicin Sales (K Unit) by Company (2015-2020)
Table 70. India Liposomal Doxorubicin Sales Market Share by Company (2015-2020)
Table 71. India Liposomal Doxorubicin Sales (K Unit) by Type (2015-2020)
Table 72. India Liposomal Doxorubicin Sales Market Share by Type (2015-2020)
Table 73. India Liposomal Doxorubicin Sales (K Unit) by Application (2015-2020)
Table 74. India Liposomal Doxorubicin Sales Market Share by Application (2015-2020)
Table 75. Johnson & Johnson Corporation Information
Table 76. Johnson & Johnson Description and Business Overview
Table 77. Johnson & Johnson Liposomal Doxorubicin Sales (K Unit), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 78. Johnson & Johnson Liposomal Doxorubicin Product
Table 79. Johnson & Johnson Recent Development
Table 80. Sun Pharmaceutical Corporation Information
Table 81. Sun Pharmaceutical Description and Business Overview
Table 82. Sun Pharmaceutical Liposomal Doxorubicin Sales (K Unit), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 83. Sun Pharmaceutical Liposomal Doxorubicin Product
Table 84. Sun Pharmaceutical Recent Development
Table 85. CSPC Corporation Information
Table 86. CSPC Description and Business Overview
Table 87. CSPC Liposomal Doxorubicin Sales (K Unit), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 88. CSPC Liposomal Doxorubicin Product
Table 89. CSPC Recent Development
Table 90. Kinyond Corporation Information
Table 91. Kinyond Description and Business Overview
Table 92. Kinyond Liposomal Doxorubicin Sales (K Unit), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 93. Kinyond Liposomal Doxorubicin Product
Table 94. Kinyond Recent Development
Table 95. Teva Corporation Information
Table 96. Teva Description and Business Overview
Table 97. Teva Liposomal Doxorubicin Sales (K Unit), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 98. Teva Liposomal Doxorubicin Product
Table 99. Teva Recent Development
Table 100. Fudan-Zhangjiang Corporation Information
Table 101. Fudan-Zhangjiang Description and Business Overview
Table 102. Fudan-Zhangjiang Liposomal Doxorubicin Sales (K Unit), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 103. Fudan-Zhangjiang Liposomal Doxorubicin Product
Table 104. Fudan-Zhangjiang Recent Development
Table 105. Zydus Cadila Corporation Information
Table 106. Zydus Cadila Description and Business Overview
Table 107. Zydus Cadila Liposomal Doxorubicin Sales (K Unit), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 108. Zydus Cadila Liposomal Doxorubicin Product
Table 109. Zydus Cadila Recent Development
Table 110. TTY Biopharma Corporation Information
Table 111. TTY Biopharma Liposomal Doxorubicin Sales (K Unit), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 112. TTY Biopharma Description and Business Overview
Table 113. TTY Biopharma Liposomal Doxorubicin Product
Table 114. TTY Biopharma Recent Development
Table 115. Production Base and Market Concentration Rate of Raw Material
Table 116. Key Suppliers of Raw Materials
Table 117. Liposomal Doxorubicin Distributors List
Table 118. Liposomal Doxorubicin Customers List
Table 119. Liposomal Doxorubicin Market Key Trends
Table 120. Liposomal Doxorubicin Key Opportunities and Drivers
Table 121. Liposomal Doxorubicin Market Challenges
Table 122. Research Programs/Design for This Report
Table 123. Key Data Information from Secondary Sources
Table 124. Key Data Information from Primary Sources
List of Figures
Figure 1. Liposomal Doxorubicin Product Picture
Figure 2. Global Liposomal Doxorubicin Sales Market Share by Type in 2020 & 2026
Figure 3. Type I Product Picture
Figure 4. Type II Product Picture
Figure 5. Global Liposomal Doxorubicin Market Share by Application in 2020 & 2026
Figure 6. Breast Cancer Examples
Figure 7. Liver Cancer Examples
Figure 8. Kidney Cancer Examples
Figure 9. Multiple Myeloma Examples
Figure 10. Ovarian Cancer Examples
Figure 11. Other Examples
Figure 12. Global Liposomal Doxorubicin Sales (K Unit) Growth Rate (2015-2026)
Figure 13. Global Liposomal Doxorubicin Revenue (US$ Million) Growth Rate (2015-2026)
Figure 14. Global Liposomal Doxorubicin Price Trends Growth Rate (2015-2026) (USD/Unit)
Figure 15. Global Liposomal Doxorubicin Revenue Market Share by Region: 2015 VS 2020
Figure 16. Global Liposomal Doxorubicin Revenue Market Share by Region: 2021 VS 2026
Figure 17. United States Liposomal Doxorubicin Revenue (Million USD) Growth Rate (2015-2026)
Figure 18. United States Liposomal Doxorubicin Sales (K Unit) Growth Rate (2015-2026)
Figure 19. Europe Liposomal Doxorubicin Revenue (Million USD) Growth Rate (2015-2026)
Figure 20. Europe Liposomal Doxorubicin Sales (Million USD) Growth Rate (2015-2026)
Figure 21. China Liposomal Doxorubicin Revenue (Million USD) Growth Rate (2015-2026)
Figure 22. China Liposomal Doxorubicin Sales (Million USD) and Growth Rate (2015-2026)
Figure 23. Japan Liposomal Doxorubicin Revenue (Million USD) Growth Rate (2015-2026)
Figure 24. Japan Liposomal Doxorubicin Sales (Million USD) Growth Rate (2015-2026)
Figure 25. Southeast Asia Liposomal Doxorubicin Revenue (Million USD) Growth Rate (2015-2026)
Figure 26. Southeast Asia Liposomal Doxorubicin Sales (Million USD) Growth Rate (2015-2026)
Figure 27. India Liposomal Doxorubicin Revenue (Million USD) Growth Rate (2015-2026)
Figure 28. India Liposomal Doxorubicin Sales (Million USD) Growth Rate (2015-2026)
Figure 29. Global 5 Largest Liposomal Doxorubicin Players Market Share by Revenue in Liposomal Doxorubicin 2015 & 2019
Figure 30. Liposomal Doxorubicin Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 31. Global Liposomal Doxorubicin Revenue Share by Type (2015-2020)
Figure 32. Global Liposomal Doxorubicin Revenue Growth Rate by Type in 2015 & 2019
Figure 33. Global Liposomal Doxorubicin Revenue Share by Application (2015-2020)
Figure 34. Global Liposomal Doxorubicin Revenue Growth Rate by Application in 2015 & 2019
Figure 35. United States Liposomal Doxorubicin Sales Market Share by Type in 2019
Figure 36. United States Liposomal Doxorubicin Sales Market Share by Type in 2019
Figure 37. Europe Liposomal Doxorubicin Sales Market Share by Company in 2019
Figure 38. Europe Liposomal Doxorubicin Sales Market Share by Type in 2019
Figure 39. Europe Liposomal Doxorubicin Sales Market Share by Application in 2019
Figure 40. China Liposomal Doxorubicin Sales Market Share by Company in 2019
Figure 41. China Liposomal Doxorubicin Sales Market Share by Type in 2019
Figure 42. China Liposomal Doxorubicin Sales Market Share by Application in 2019
Figure 43. Japan Liposomal Doxorubicin Sales Market Share by Company in 2019
Figure 44. Japan Liposomal Doxorubicin Sales Market Share by Type in 2019
Figure 45. Japan Liposomal Doxorubicin Sales Market Share by Application in 2019
Figure 46. Southeast Asia Liposomal Doxorubicin Sales Market Share by Company in 2019
Figure 47. Southeast Asia Liposomal Doxorubicin Sales Market Share by Type in 2019
Figure 48. Southeast Asia Liposomal Doxorubicin Sales Market Share by Application in 2019
Figure 49. India Liposomal Doxorubicin Sales Market Share by Company in 2019
Figure 50. India Liposomal Doxorubicin Sales Market Share by Type in 2019
Figure 51. India Liposomal Doxorubicin Sales Market Share by Application in 2019
Figure 52. Key Raw Materials Price Trend
Figure 53. Manufacturing Cost Structure of Liposomal Doxorubicin
Figure 54. Manufacturing Process Analysis of Liposomal Doxorubicin
Figure 55. Liposomal Doxorubicin Industrial Chain Analysis
Figure 56. Channels of Distribution
Figure 57. Distributors Profiles
Figure 58. Porter's Five Forces Analysis
Figure 59. Bottom-up and Top-down Approaches for This Report
Figure 60. Data Triangulation
Figure 61. Key Executives Interviewed
ドキソルビシンの世界市場レポート2020 Market Analysis and Insights: Global Doxorubicin Market The global Doxorubicin market size is projected to reach US$ 1081.6 million by 2026, from US$ 870.5 million in 2020, at a CAGR of 3.7% during 2021-2026. Global Doxorubicin Scope and Market Size The global Doxorubicin market is segmented by comp…- リポソームドラッグデリバリーの世界市場レポート2020 Liposomes have been used to improve the therapeutic index of new or established drugs by modifying drug absorption, reducing metabolism, prolonging biological half-life or reducing toxicity. Drug distribution is then controlled primarily by properties of the carrier and no longer by physico-chemical…
- 乳がん検診の世界市場レポート2020 Breast cancer screening is the medical screening of asymptomatic, apparently healthy women for breast cancer in an attempt to achieve an earlier diagnosis. A number of screening tests have been employed, including clinical and self-breast exams, mammography, genetic screening, ultrasound, and magnet…
- 乳がん治療薬の世界市場レポート2020 Medicines include tamoxifen (Nolvadex) for women before and after menopause and aromatase inhibitors including anastrozole (Arimidex), exemestane (Aromasin), and letrozole (Femara) for postmenopausal women. Side effects can include hot flashes and vaginal dryness Market Analysis and Insights: Global…
- がん診断装置の世界市場レポート2020 Diagnostic testing involves tests and procedures to confirm the presence of disease and identify the correct tumor type, location, extent and stage. A key market driver powering the growth of the cancer diagnostic devices market is the need for cost cutting by pharma companies. Pharmaceutical compan…